Skip to main content

Carteolol Side Effects

Applies to carteolol: oral tablet.


Carteolol is generally well-tolerated. Side effects are usually mild and transient.[Ref]

Nervous system

Nervous system side effects include headache in up to 1% to 17%, asthenia in 8%, insomnia in 5%, dizziness in 8%, paresthesias in 2%, and vertigo, nervousness, headache or fatigue in 1% of patients.[Ref]


Cardiovascular problems include chest pain in 2% and edema in 1% of patients. Carteolol may cause or worsen AV heart block. In the rare cases of new or worsened congestive heart failure that are associated with carteolol, a cause-and-effect relationship is not established.[Ref]

The etiology of "chest pain" was not described in studies and reviews from the medical literature.[Ref]


Gastrointestinal complaints of abdominal or epigastric pain in 1% to 7% and diarrhea or nausea in 2% of patients is reported.[Ref]


Respiratory side effects are rare. Cough, pharyngitis, or sinusitis are reported in 1% to 5% of patients. Dyspnea is reported rarely. Patients with a history of reactive airways disease may be more likely to become short of breath while taking carteolol, as during therapy with any beta-blocker.[Ref]


Carteolol and pindolol, beta-adrenergic receptor antagonists with intrinsic sympathomimetic activity (ISA), have more commonly been associated with muscle cramps and elevated serum creatine phosphokinase (CK) levels than beta-blockers without ISA.[Ref]

Musculoskeletal pain is reported in approximately 3% to 13% of patients.[Ref]


Genitourinary complaints of impotence are reported in less than 1% of male patients.[Ref]


Psychiatric side effects including reports of depression have been associated with carteolol.[Ref]


1. "Multum Information Services, Inc. Expert Review Panel"

2. Tarkiainen A, Saraste K, Seppala T, Gordin A, Auvinen J "A controlled study of the antihypertensive effect of carteolol, a new beta-adrenergic receptor blocking drug, in combination with hydrochlorothiazide and amiloride." Eur J Clin Pharmacol 19 (1981): 239-44

3. Simon H, Schuppan U "The treatment of angina pectoris with the new beta-receptor blocker carteolol. Results of a controlled trial in comparison with pindolol." Arzneimittelforschung 33 (1983): 318-21

4. Frishman WH, Covey S "Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism." J Clin Pharmacol 30 (1990): 412-21

5. Luther RR, Glassman HN, Jordan DC "A comparison of carteolol and nadolol in the treatment of stable angina pectoris." J Clin Pharmacol 28 (1988): 634-9

6. Velasquez MT, Byrne D, Hoffmann RG "Antihypertensive effect of carteolol in thiazide-treated hypertensive subjects." J Clin Pharmacol 25 (1985): 601-6

7. Luther RR, Maurath CJ, Klepper MJ, Peckinpaugh RO, Ringham GL "Carteolol treatment of essential hypertension: a long-term study of safety and efficacy." J Int Med Res 14 (1986): 175-84

8. Luther RR, Glassman HN, Jordan DC, Klepper MJ "Long-term treatment of angina pectoris with carteolol: a new beta-adrenergic receptor blocking agent." J Int Med Res 14 (1986): 167-74

9. "Carteolol and penbutolol for hypertension." Med Lett Drugs Ther 31 (1989): 70-1

10. Imai Y, Watanabe N, Hashimoto J, Nishiyama A, Sakuma H, Sekino H, Omata K, Abe K "Muscle cramps and elevated serum creatine phosphokinase levels induced by beta-adrenoceptor blockers." Eur J Clin Pharmacol 48 (1995): 29-34

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.